Valuation: Johnson & Johnson

Capitalization 578B 489B 449B 425B 789B 52,384B 825B 5,213B 2,064B 25,218B 2,168B 2,124B 90,780B P/E ratio 2025
18.8x
P/E ratio 2026 * 24.4x
Enterprise value 603B 510B 468B 443B 822B 54,610B 860B 5,435B 2,152B 26,290B 2,261B 2,214B 94,638B EV / Sales 2025
5.31x
EV / Sales 2026 * 5.93x
Free-Float
77.08%
Yield 2025 *
2.15%
Yield 2026 * 2.21%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.93%
1 week+5.61%
Current month+5.61%
1 month+15.66%
3 months+28.63%
6 months+39.91%
Current year+15.97%
More quotes
1 week 227.25
Extreme 227.25
240.94
1 month 203.85
Extreme 203.85
240.94
Current year 200.91
Extreme 200.9101
240.94
1 year 141.5
Extreme 141.5
240.94
3 years 140.68
Extreme 140.68
240.94
5 years 140.68
Extreme 140.68
240.94
10 years 99.98
Extreme 99.98
240.94
More quotes
Manager TitleAgeSince
Chief Executive Officer 63 2022-01-02
Director of Finance/CFO 59 2018-06-30
Chief Tech/Sci/R&D Officer 61 2024-07-31
Director TitleAgeSince
Director/Board Member 72 2009-10-22
Director/Board Member 62 2013-10-14
Director/Board Member 71 2015-06-08
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.93%+5.61%+56.73%+46.87% 578B
+3.66%+2.03%+20.48%+211.52% 947B
+2.01%+0.19%+17.22%+53.94% 395B
-0.64%+1.63%+23.32%+25.27% 367B
+1.82%+10.57%+39.70%+15.38% 303B
+0.89%+3.71%+21.59%+33.23% 298B
+0.57%+4.66%+23.89%+51.27% 295B
+5.29%-20.04%-53.01%-38.83% 208B
+4.49%+12.41%+30.93%+57.51% 207B
+2.10%+7.43%+58.79%+77.22% 189B
Average +2.11%+2.72%+23.96%+53.34% 378.65B
Weighted average by Cap. +2.11%+2.84%+26.29%+80.87%
See all sector performances

Financials

2025 2026 *
Net sales 93.76B 79.37B 72.74B 68.89B 128B 8,494B 134B 845B 335B 4,089B 352B 344B 14,720B 101B 85.14B 78.03B 73.91B 137B 9,112B 143B 907B 359B 4,387B 377B 369B 15,791B
Net income 26.5B 22.44B 20.56B 19.48B 36.16B 2,401B 37.81B 239B 94.6B 1,156B 99.4B 97.35B 4,161B 23.64B 20.01B 18.34B 17.37B 32.25B 2,141B 33.72B 213B 84.36B 1,031B 88.64B 86.81B 3,711B
Net Debt 24.58B 20.8B 19.07B 18.06B 33.53B 2,227B 35.06B 222B 87.72B 1,072B 92.17B 90.27B 3,858B 17.99B 15.23B 13.96B 13.22B 24.55B 1,630B 25.67B 162B 64.22B 785B 67.48B 66.09B 2,825B
More financial data * Estimated data
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; At the end of 2024, Johnson & Johnson has 64 manufacturing facilities located in the United States (23), North America (7), Europe (21), Africa and Asia/Pacific (13). The United States accounts for 56.6% of net sales.
Employees
138,100
Calendar
Feb. 23 -
More about the company
Date Price Change Volume
26-02-06 239.99 $ +0.93% 8,274,034
26-02-05 237.79 $ +1.42% 10,267,498
26-02-04 234.47 $ +0.59% 8,641,449
26-02-03 233.10 $ +1.02% 9,346,605
26-02-02 230.75 $ +1.54% 8,187,529

Delayed Quote Nyse, February 06, 2026 at 04:00 pm EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
239.99USD
Average target price
231.25USD
Spread / Average Target
-3.64%
Consensus

Quarterly revenue - Rate of surprise